BlackRock Fund Advisors’s Regenxbio RGNX Stock Holding History

BlackRock Fund Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$19.2M	Buy	1,034,945 +465,219	+82%	+$8.89M	﹤0.01%	2209
2016 Q3	$7.98M	Buy	569,726 +53,547	+10%	+$591K	﹤0.01%	2590
2016 Q2	$4.13M	Buy	516,179 +330,862	+179%	+$3.67M	﹤0.01%	2911
2016 Q1	$2M	Sell	185,317 -9,804	-5%	-$125K	﹤0.01%	3079
2015 Q4	$3.24M	Buy	+195,121	New	+$3.87M	﹤0.01%	3021

Other funds holding RGNX

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

BlackRock Fund Advisors's RGNX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Regenxbio (RGNX) stake by 82% in Q4 2016, buying an estimated $8.89M and bringing the position to 1,034,945 shares worth $19.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2209.

BlackRock Fund Advisors first reported a position in RGNX in Q4 2015 and has held it in 5 quarters since. 78 funds tracked by Wall St. Rank hold RGNX as of Q4 2016.

BlackRock Fund Advisors held 1,034,945 shares of Regenxbio worth $19.2M as of Q4 2016.
BlackRock Fund Advisors bought 465,219 Regenxbio shares in Q4 2016, an estimated $8.89M.
Regenxbio made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2209 holding.
BlackRock Fund Advisors first reported a position in Regenxbio in Q4 2015 and has held it in 5 quarters since.
78 funds tracked by Wall St. Rank held Regenxbio as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.